Form 4 for SGRY Surgery Partners, Inc.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-29 · accession 0001638833-23-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-03 | 2023-06-29 | SGRY | Evans Jason Eric | CEO | S - Sale | $45.10 | -1,892 | 424.9K | -0.4% | -$85.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-29 | S | D | 1,892 | $45.10 | 424,898 | D | — | — | (F1) This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 3/24/2023. The Rule 10b5-1 trading plan, which was structured to include several sale periods, was established as part of the Reporting Person's long-term strategy for asset diversification and financial, retirement, estate and tax planning activities over a period of time. (F2) The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |